Alnylam Pharmaceuticals | ALNY - 贸易债权人

金融业

USD

USD 5.13B

现金及等价物

USD 1.71B

USD 211.12M

USD 4.22B

USD 1.35B

USD 1.28B

USD 137.59M

USD 145.22M

2.23K

EPS每股收益

USD 1.99

股本和储备

USD 1.08B

USD 825.01M

债务利息支出

USD 69.29M

USD 26.63M

USD 2.48B

USD 39.56B

USD 205.99M

USD 898.54M

USD 137.59M

普通股股本

USD 133.44M

80.04

USD 221.65M

USD 1.17B

销售和管理费用

USD 282.51M

USD 200.15M

贸易债权人

USD 126.63M

应收帐款人

USD 883.96M

	贸易债权人	更改		日
Acadia Pharmaceuticals	USD 12.25M		1.34M	2026-03
Agios Pharmaceuticals	USD 13.75M		4.61M	2026-03
Alnylam Pharmaceuticals	USD 126.63M		10.91M	2026-03
Amgen	USD 19.52B		1.37B	2026-03
Arrowhead Research	USD 30.75M		2.19M	2026-03
BioCryst Pharmaceuticals	USD 10.96M		4.87M	2026-03
BioMarin Pharmaceutical	USD 793.15M		34.12M	2026-03
Incyte	USD 228.62M		1.41B	2026-03
Ionis Pharmaceuticals	USD 26.03M		2.05M	2026-03
Moderna	USD 161M		156M	2026-03
Neurocrine Biosciences	USD 691.3M		145.8M	2026-03
Novartis	USD 4.32B		134M	2026-03
PTC Therapeutics	USD 25.48M		20M	2026-03
Regeneron Pharmaceuticals	USD 1.03B		4.81B	2026-03
Sangamo BioSciences	USD 10.74M		7.46M	2025-06
Sanofi	EUR 22.71B		219M	2026-03
Sarepta Therapeutics	USD 70.38M		210.46M	2026-03
Takeda	JPY 491.34B		23.75B	2026-03
Tectonic Therapeutic	USD 2.55M		1.46M	2026-03
Ultragenyx Pharmaceutical	USD 42M		11M	2026-03
Vertex Pharmaceuticals	USD 3.47B		40.6M	2026-03
Xencor	USD 7.92M		2.91M	2026-03